You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

January 21, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

[BLOG]: Pipeline advancement responsible for upturn in global pharma R&D

The world's leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year. » Find out what Merck, Pfizer, Gilead and others spent on R&D

Simulated IV saline products under FDA investigation

FDA and the Centers for Disease Control and Prevention (CDC) continue to investigate multiple instances of Wallcur's simulated intravenous (IV) saline products being administered to patients. These products are not sterile and should not be injected in humans or animals. » How to be more vigilant with IV products

Continuing Education

MTM opportunities in caring for the patient with cardiovascular disease

This month's CE activity is the last unit of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. Running from February 2014 through January 2015, the series enables pharmacists to earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to empower pharmacists to engage patients with cardiovascular disease in the practices of self-management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT01-JKF33.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Temporary tattoo for glucose monitoring in development

Researchers from the University of California, San Diego, are working on a non-invasive glucose-monitoring device that can be placed on the skin of patients with diabetes to measure their glucose levels. » Read more about this tattoo-based biosensor

 
Advertisement

RELATED ARTICLES

2014 drug costs soar, no end in sight

[BLOG]: A better IV compounding strategy: Leveraging in-house advantage

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group